Drug profile · INN
hydrocortamate hydrochloride
MAGNACORT
hydrocortamate hydrochloride (MAGNACORT) is a glucocorticoid receptor agonist. Route of administration: topical. Current US regulatory status: approved.
Drug details — hydrocortamate hydrochloride
- US status
- approved
- Class
- —
- Route
- TOPICAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
hydrocortamate hydrochloride (MAGNACORT) is a glucocorticoid receptor agonist. Route of administration: topical. Current US regulatory status: approved.
Key facts
Mechanism of action
Glucocorticoid receptor agonist
Primary target: Glucocorticoid receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is hydrocortamate hydrochloride?
hydrocortamate hydrochloride (MAGNACORT) is a glucocorticoid receptor agonist. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for hydrocortamate hydrochloride?
MAGNACORT is a marketed brand name for hydrocortamate hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of hydrocortamate hydrochloride?
hydrocortamate hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.